S1 Episode 5: Multiple Myeloma Therapies: A Glimpse Into the Future

S1 Episode 5: Multiple Myeloma Therapies: A G...

MEDSCAPEMEDSCAPE

‏التالي

S1 Episode 6: Disparities in Multiple Myeloma: Exposing the Problem and Paving a Path Forward

Drs Joseph Mikhael and Brandon Blue reveal the impact of disparities in multiple myeloma and pave a path forward to culturally competent care. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/964342). The topics and d ...  عرض المزيد

 . 25 دقيقة و18 ثانية
S2 Episode 1: Managing Side Effects and Maximizing Quality of Life in Multiple Myeloma Patients

Joseph Mikhael, MD, and Surbhi Sidana, MD, discuss the importance of balancing treatment intervals, managing side effects, and maximizing quality of life in multiple myeloma patients. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.c ...  عرض المزيد

 . 23 دقيقة و58 ثانية

‏حلقات موصى بها

S1 Episode 6: New and Emerging Therapies in HIV Treatment
Medscape InDiscussion: HIV

Drs Michael Saag and Judith Currier discuss options for long-acting HIV therapies, minimizing patient interactions with the healthcare system, and honoring patient preferences. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/vie ...  عرض المزيد

 . 21 دقيقة و17 ثانية
S1 Episode 3: Antiretroviral Therapy, Maintenance, and Switching
Medscape InDiscussion: HIV

Drs Michael Saag and Constance Benson discuss antiretroviral therapy, maintenance, and switching. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/963238). The topics and discussions are planned, produced, and rev ...  عرض المزيد

 . 22 دقيقة و31 ثانية
Ep. 267 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill
BackTable Urology

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ...  عرض المزيد

 . 1 ساعة و 0 دقيقة متبقية
Primary resistance to BCMA-targeted bispecifics in multiple myeloma, emapalumab therapy in hemophagocytic lymphohistiocytosis, and chemotherapy-induced pyroptosis as a mechanism of thrombus formation
Blood Podcast

In this week's episode, we’ll learn more about mechanisms of primary resistance to BCMA-targeted bispecific T-cell engagers in relapsed/refractory multiple myeloma, the effects of emapalumab therapy on outcomes in patients with pediatric hemophagocytic lymphohistiocytosis who rec ...  عرض المزيد

 . 20 دقيقة و5 ثانية